Literature DB >> 1448927

Complex intrapatient sequence variation in the V1 and V2 hypervariable regions of the HIV-1 gp 120 envelope sequence.

L Pedroza Martins1, N Chenciner, S Wain-Hobson.   

Abstract

Human immunodeficiency virus (HIV) quasi-species fluctuate both in time and in space. In general intrapatient variation is less extensive than interpatient variation. The V1 and V2 hypervariable regions of the envelope gene were analyzed for patient samples harboring highly divergent genomes in other loci. Proviral sequences were amplified by PCR, cloned, and sequenced. It was concluded that intrapatient variation may exceed interpatient variation but the presence of two clearly distinct populations was not confirmed. The env hypervariable regions appeared to be evolving independently of one another, cautioning against extrapolation of data, particularly from the V3 region. Virus typing and the assessment of HIV superinfection by genetic methods will prove difficult and experimental approaches will have to be carefully designed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1448927     DOI: 10.1016/0042-6822(92)90259-r

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  20 in total

1.  Human immunodeficiency virus type 1 clade B superinfection: evidence for differential immune containment of distinct clade B strains.

Authors:  Otto O Yang; Eric S Daar; Beth D Jamieson; Arumugam Balamurugan; Davey M Smith; Jacqueline A Pitt; Christos J Petropoulos; Douglas D Richman; Susan J Little; Andrew J Leigh Brown
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

2.  Exploration of antigenic variation in gp120 from clades A through F of human immunodeficiency virus type 1 by using monoclonal antibodies.

Authors:  J P Moore; F E McCutchan; S W Poon; J Mascola; J Liu; Y Cao; D D Ho
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

3.  Spatial discontinuities in human immunodeficiency virus type 1 quasispecies derived from epidermal Langerhans cells of a patient with AIDS and evidence for double infection.

Authors:  M Sala; G Zambruno; J P Vartanian; A Marconi; U Bertazzoni; S Wain-Hobson
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

4.  Study of the dynamics of neutralization escape mutants in a chimpanzee naturally infected with the simian immunodeficiency virus SIVcpz-ant.

Authors:  P N Nyambi; P Lewi; M Peeters; W Janssens; L Heyndrickx; K Fransen; K Andries; M Vanden Haesevelde; J Heeney; P Piot; G van der Groen
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

5.  In vivo sequence diversity of the protease of human immunodeficiency virus type 1: presence of protease inhibitor-resistant variants in untreated subjects.

Authors:  W J Lech; G Wang; Y L Yang; Y Chee; K Dorman; D McCrae; L C Lazzeroni; J W Erickson; J S Sinsheimer; A H Kaplan
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

Review 6.  Clinical use of quantitative molecular methods in studying human immunodeficiency virus type 1 infection.

Authors:  M Clementi; S Menzo; P Bagnarelli; A Valenza; S Paolucci; R Sampaolesi; A Manzin; P E Varaldo
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

7.  Clonal expansion of human T-cell leukemia virus type I-infected cells in asymptomatic and symptomatic carriers without malignancy.

Authors:  E Wattel; J P Vartanian; C Pannetier; S Wain-Hobson
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

8.  Probing the structure of the V2 domain of human immunodeficiency virus type 1 surface glycoprotein gp120 with a panel of eight monoclonal antibodies: human immune response to the V1 and V2 domains.

Authors:  J P Moore; Q J Sattentau; H Yoshiyama; M Thali; M Charles; N Sullivan; S W Poon; M S Fung; F Traincard; M Pinkus
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

9.  Quantitative molecular monitoring of human immunodeficiency virus type 1 activity during therapy with specific antiretroviral compounds.

Authors:  P Bagnarelli; S Menzo; A Valenza; S Paolucci; S Petroni; G Scalise; R Sampaolesi; A Manzin; P E Varaldo; M Clementi
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

10.  Simian immunodeficiency virus promoter exchange results in a highly attenuated strain that protects against uncloned challenge virus.

Authors:  Philippe Blancou; Nicole Chenciner; Raphaël Ho Tsong Fang; Valérie Monceaux; Marie-Christine Cumont; Denise Guétard; Bruno Hurtrel; Simon Wain-Hobson
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.